Abstract:Background: Drug shortages significantly threaten public health and medical service provision worldwide. Research evidence on the complete picture of drug shortages is currently scant in China. This study aimed to provide a descriptive overview and a reference for alleviating of drug shortages in China. Methods: National and provincial lists of drug shortages issued in China from 2018 to 2021 were collected and summarized. The information on essential medicines, medical insurance drugs, emergency drugs, and volume-based purchasing drugs was then matched with a drug shortage list to analyse the characteristics, proportion and incidence of drug shortage on each list based on the analysis of information such as dosage form, shortage frequency, and Anatomical Therapeutic Chemical (ATC) classification of the drugs in shortage. Results: A total of 24 provinces issued drug shortages lists involving 408 drugs from 2018 to 2021. All 58 drugs in the national drug list were included on the provincial drug shortage list. Among all the drugs in shortage, the most significant shortage involved injections, accounting for 45.3% (185/408). Ninety-five drugs (23.3%) were in shortage 5 times (annual shortage > 1 time) or more in the provincial lists, and 199 drugs (48.8%) were on the shortage list only once. In terms of therapeutic property, nearly all categories of drugs had been reported in shortage, among which cardiovascular drugs, nervous system drugs, anti-tumor and immunomodulatory drugs, and blood and hematopoietic organ drugs accounted for more than 10%. There is no significant difference in drug shortage among economic regions. Comparing drugs in shortage and various lists, 81.9% (334/408), 51.0% (208/408) and 67.9% (277/408) fell on the National Medical Insurance Drug List, National Essential Medicines List, and WHO Model List of Essential Medicines, respectively, while the volume-based purchasing drugs accounted for 3.4% (14 drugs). The incidence of drug shortages on NEML, WHO Model List of Essential Medicines and medical insurance category A was significantly higher than that of medical insurance category B and volume-based purchasing drugs (P < 0.05). Of the Emergency Drugs List, 72.0% (36/50) also experienced shortages, significantly higher than all the above categories (P < 0.05). Conclusions: In China, drug shortages were severe and complicated. Drug shortages vary among economic regions but are not significant. In comparison, the national procurement pattern of volume-based drug purchasing may be conducive to alleviating the drug shortage problem. Collaboration of all partners was recommended to ensure the supply of clinically necessary drugs.

Analysis and Suggestions on current situation of Chinese Drug Shortage Problem

Survey and Analysis on Drug Shortage in China

A Review of Research on Drug Shortages in China

Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China

Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study

International Experiences of Response to Medicines Shortage and the Implications to China

Investigation and Analysis of the Reasons for Drug Shortage from 26 Medical Institutions in China

Drug shortages in China: a cross-sectional study

Trends of Drug Shortages in China from 2018 to 2020: A Retrospective Observational Study

The impact of drug shortages on drug prices: evidence from China

Policy analysis on ensuring production and supply of fewer essential medicines: Based on the theory of generator behavior

Causes of the unduly rapid growth of drug expenses in China and countermeasures

The Study on the Countermeasures of Shortage of High-quality and Low-cost Drugs

Investigation of the Availability and Accessibility of Essential Drugs Based on Experience Abroad

Evidence-based Evaluation of Monitoring System for Global Short Drugs

The Current Status and Effects of Emergency Drug Shortages in China: Perceptions of Emergency Department Physicians

Whether medicine supply is really meeting primary health care needs: a mixed-methods study in Shandong Province, China

Study on the Current Status and Intervention Measures of Essential Medicine in Short Supply

Analysis of Current Situation and Countermeasures of Drug Supply Chain of Centralized Procurement in China

Analysis of Resolving the Problems of Shortage of Essential Drugs Based on the Perspective of Sale Terminals